Clinical Trial Update: Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) [Phase 2]

View source ↗

Summary

A Phase 2 trial in Canada evaluated the safety and effects of MDMA-assisted psychotherapy for Posttraumatic Stress Disorder. The study is completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-07-01